Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

CLOCK and BMAL1 Regulate Muscle Insulin Sensitivity via SIRT1 in Male Mice.

Endocrinology | 2016

Circadian misalignment induces insulin resistance in both human and animal models, and skeletal muscle is the largest organ response to insulin. However, how circadian clock regulates muscle insulin sensitivity and the underlying molecular mechanisms are still largely unknown. Here we show circadian locomotor output cycles kaput (CLOCK) and brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein (BMAL)-1, two core circadian transcription factors, are down-regulated in insulin-resistant C2C12 myotubes and mouse skeletal muscle. Furthermore, insulin signaling is attenuated in the skeletal muscle of Clock(Δ19/Δ19) mice, and knockdown of CLOCK or BMAL1 by small interfering RNAs induces insulin resistance in C2C12 myotubes. Consistently, ectopic expression of CLOCK and BMAL1 improves insulin sensitivity in C2C12 myotubes. Moreover, CLOCK and BMAL1 regulate the expression of sirtuin 1 (SIRT1), an important regulator of insulin sensitivity, in C2C12 myotubes and mouse skeletal muscle, and two E-box elements in Sirt1 promoter are responsible for its CLOCK- and BMAL1-dependent transcription in muscle cells. Further studies show that CLOCK and BMAL1 regulate muscle insulin sensitivity through SIRT1. In addition, we find that BMAL1 and SIRT1 are decreased in the muscle of mice maintained in constant darkness, and resveratrol supplementation activates SIRT1 and improves insulin sensitivity. All these data demonstrate that CLOCK and BMAL1 regulate muscle insulin sensitivity via SIRT1, and activation of SIRT1 might be a potential valuable strategy to attenuate muscle insulin resistance related to circadian misalignment.

Pubmed ID: 27035655 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


BRF1/2 Antibody (antibody)

RRID:AB_10695874

This polyclonal targets BRF1/2

View all literature mentions

SirT1 (1F3) (antibody)

RRID:AB_10999470

This monoclonal targets SirT1

View all literature mentions

Anti-PER2 antibody (antibody)

RRID:AB_2630357

This polyclonal targets

View all literature mentions

KAT13D / CLOCK antibody - ChIP Grade (antibody)

RRID:AB_303866

This polyclonal targets KAT13D / CLOCK antibody - ChIP Grade

View all literature mentions

Phospho-Akt (Ser473) (193H12) Rabbit mAb (antibody)

RRID:AB_331168

This monoclonal targets Phospho-Akt (Ser473) (193H12) Rabbit mAb

View all literature mentions

Phospho-GSK-3 (Ser9) Antibody (antibody)

RRID:AB_331405

This polyclonal targets Phospho-GSK-3 (Ser9)

View all literature mentions

Phospho-IGF-I Receptor beta (Tyr1131)/Insulin Receptor beta (Tyr1146) Antibody (antibody)

RRID:AB_331578

This polyclonal targets Phospho-IGF-I Receptor beta (Tyr1131)/Insulin Receptor beta (Tyr1146)

View all literature mentions

p53 (1C12) Mouse mAb (antibody)

RRID:AB_331743

This monoclonal targets p53 (1C12) Mouse mAb

View all literature mentions

NFkB p65 (acetyl K310) antibody - ChIP Grade (antibody)

RRID:AB_776753

This polyclonal targets Mouse NFkB p65 (acetyl K310)

View all literature mentions

Acetyl-p53 (Lys379) Antibody (antibody)

RRID:AB_823591

This polyclonal targets Acetyl-p53 (Lys379)

View all literature mentions